s-nitroso-n-acetylpenicillamine has been researched along with Abdominal Migraine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Guo, Y; Li, AR; Man, YH; Wang, P; Yao, G; Zhou, YF | 1 |
| Bolay, H; Chiarugi, A; Moskowitz, MA; Reuter, U | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Abdominal Migraine
| Article | Year |
|---|---|
NO up-regulates migraine-related CGRP via activation of an Akt/GSK-3β/NF-κB signaling cascade in trigeminal ganglion neurons.
Topics: Calcitonin Gene-Related Peptide; Cells, Cultured; Glycogen Synthase Kinase 3 beta; Humans; Migraine Disorders; Nitric Oxide; Nitric Oxide Donors; Proto-Oncogene Proteins c-akt; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Transcription Factor RelA; Trigeminal Ganglion | 2020 |
Nuclear factor-kappaB as a molecular target for migraine therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents | 2002 |